DETECTION OF ANTIBODIES TO HIV-1 GP41-DERIVED AND HLA CLASS-II ANTIGEN-DERIVED PEPTIDES IN SLE PATIENTS
Citation
K. Koshino et al., DETECTION OF ANTIBODIES TO HIV-1 GP41-DERIVED AND HLA CLASS-II ANTIGEN-DERIVED PEPTIDES IN SLE PATIENTS, Scandinavian journal of rheumatology, 24(5), 1995, pp. 288-292
Categorie Soggetti
Rheumatology
SICI code
0300-9742(1995)24:5<288:DOATHG>2.0.ZU;2-U
Abstract
A role for viruses in the pathogenesis of human autoimmune diseases ha
s long been suspected but has not yet been proven. Highly conserved ho
mologous regions has been reported in the carboxy terminus of human im
munodeficiency virus (HIV)-1 gp41 (amino acids 838-844) and the amino-
terminal of the beta chain of all human HLA class II antigens (amino a
cids 19-25). This molecular mimicry between HIV-1 and HLA class II ant
igens may lead to the generation of autoantibodies and may contribute
to the development of autoimmune phenomena in HIV infected patients. W
e detected antibodies for these homologous peptides from HLA class II
and HIV-1 gp41 in systemic lupus erythematosus (SLE) patients without
HIV-I infection. Thirty-seven percent of the SLE patients had IgM anti
bodies reacting with both HLA class II- and HIV-1 gp41-derived peptide
s. These results suggest the possibility that a retrovirus may be one
of the causative agents of SLE.